U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07377591) titled 'A Study of HDM2006 in Patients With Advanced Solid Tumor' on Jan. 11.
Brief Summary: This is a first-in-human (FIH) study to evaluate the safety and preliminary efficacy of experimental drug HDM2006 in patients with advanced solid tumors.
Study Start Date: Dec. 31, 2024
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumors
Intervention:
DRUG: HDM2006
Oral administration within half an hour after a meal, QD
Recruitment Status: RECRUITING
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Disclaimer: Curated by HT Syndication....